I Sens Inc
KOSDAQ:099190
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
I Sens Inc
Total Current Liabilities
I Sens Inc
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Total Current Liabilities
₩166.9B
|
CAGR 3-Years
31%
|
CAGR 5-Years
39%
|
CAGR 10-Years
25%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Total Current Liabilities
₩80.2B
|
CAGR 3-Years
30%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Total Current Liabilities
₩50B
|
CAGR 3-Years
2 454%
|
CAGR 5-Years
658%
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Total Current Liabilities
₩8.9B
|
CAGR 3-Years
42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Total Current Liabilities
₩3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
N
|
NextBioMedical Co Ltd
KOSDAQ:389650
|
Total Current Liabilities
₩11.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
I Sens Inc
Glance View
i-SENS, Inc. engages in development and manufacture of medical, environmental, industrial sensors. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-01-30. The Company’s products consist of blood glucose monitoring systems, including blood glucose monitors, blood glucose meters, glucose monitors, blood glucose meter kits and blood sugar meters under the brand names of CareSens, MedTrust, BGStar, Barozen and others; electrolyte analyzers and cartridges; immunosensors, as well as other related accessories, such as connectors, lancets, blood glucose data management software and lancing devices, among others. The firm distributes its products within domestic market and to overseas markets including Japan, Europe, the United States and others.
See Also
What is I Sens Inc's Total Current Liabilities?
Total Current Liabilities
166.9B
KRW
Based on the financial report for Dec 31, 2025, I Sens Inc's Total Current Liabilities amounts to 166.9B KRW.
What is I Sens Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
25%
Over the last year, the Total Current Liabilities growth was 49%. The average annual Total Current Liabilities growth rates for I Sens Inc have been 31% over the past three years , 39% over the past five years , and 25% over the past ten years .
